(Q84698071)

English

Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study

scientific article published on 06 August 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20693429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20693429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Hisashi Sakamaki

19

object named as

Hisashi Sakamaki

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20693429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Chiaki Nakaseko

9

object named as

Chiaki Nakaseko

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20693429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

6

object named as

Noriko Usui

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20693429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Shigeki Ohtake

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20693429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Shuichi Miyawaki

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20693429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Hiroyuki Fujita

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20693429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Hitoshi Kiyoi

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20693429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Katsuji Shinagawa

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20693429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Hirokazu Okumura

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20693429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Koichi Miyamura

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20693429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Yasushi Miyazaki

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20693429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Atsushi Fujieda

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20693429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Tadashi Nagai

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20693429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Takahisa Yamane

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20693429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Masafumi Taniwaki

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20693429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Masatomo Takahashi

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20693429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Fumiharu Yagasaki

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20693429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Yukihiko Kimura

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20693429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Norio Asou

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20693429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Hiroshi Handa

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20693429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Sumihisa Honda

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20693429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Kazunori Ohnishi

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20693429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Tomoki Naoe

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20693429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Ryuzo Ohno

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20693429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20693429

18 June 2024

publication date

6 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20693429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

full work available at URL

http://www.bloodjournal.org/content/117/8/2358.full.pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20693429

18 June 2024

http://www.bloodjournal.org/cgi/content/abstract/117/8/2358

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20693429

18 June 2024

http://ashpublications.org/blood/article-pdf/117/8/2358/1495456/zh800811002358.pdf

Portable Document Format

1 reference

10.1182/BLOOD-2010-03-273243

https://api.crossref.org/works/10.1182/BLOOD-2010-03-273243

18 June 2024

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20693429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

117

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20693429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20693429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

2358-2365

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20693429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Acute myeloid leukemia

2

1 reference

10.1182/BLOOD-2010-03-273243

https://api.crossref.org/works/10.1182/BLOOD-2010-03-273243

18 June 2024

Drug therapy for acute myeloid leukemia

3

1 reference

10.1182/BLOOD-2010-03-273243

https://api.crossref.org/works/10.1182/BLOOD-2010-03-273243

18 June 2024

A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group Study

6

1 reference

10.1182/BLOOD-2010-03-273243

https://api.crossref.org/works/10.1182/BLOOD-2010-03-273243

18 June 2024

Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia: the JALSG AML95 study

9

1 reference

10.1182/BLOOD-2010-03-273243

https://api.crossref.org/works/10.1182/BLOOD-2010-03-273243

18 June 2024

A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan A

10

1 reference

10.1182/BLOOD-2010-03-273243

https://api.crossref.org/works/10.1182/BLOOD-2010-03-273243

18 June 2024

Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia: results of the JALSG AML97 study

11

1 reference

10.1182/BLOOD-2010-03-273243

https://api.crossref.org/works/10.1182/BLOOD-2010-03-273243

18 June 2024

Randomized study of individualized induction therapy with or without vincristine, and of maintenance-intensification therapy between 4 or 12 courses in adult acute myeloid leukemia. AML-87 Study of the Japan Adult Leukemia Study Group

12

1 reference

10.1182/BLOOD-2010-03-273243

https://api.crossref.org/works/10.1182/BLOOD-2010-03-273243

18 June 2024

Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukemia. The Japan Leukemia Study Group

13

1 reference

10.1182/BLOOD-2010-03-273243

https://api.crossref.org/works/10.1182/BLOOD-2010-03-273243

18 June 2024

Role of daunorubicin in the induction therapy for adult acute myeloid leukemia

15

1 reference

10.1182/BLOOD-2010-03-273243

https://api.crossref.org/works/10.1182/BLOOD-2010-03-273243

18 June 2024

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

17

1 reference

10.1182/BLOOD-2010-03-273243

https://api.crossref.org/works/10.1182/BLOOD-2010-03-273243

18 June 2024

"Proving the null hypothesis" in clinical trials

18

1 reference

10.1182/BLOOD-2010-03-273243

https://api.crossref.org/works/10.1182/BLOOD-2010-03-273243

18 June 2024

Nonparametric Estimation from Incomplete Observations

19

1 reference

10.1182/BLOOD-2010-03-273243

https://api.crossref.org/works/10.1182/BLOOD-2010-03-273243

18 June 2024

Asymptotically Efficient Rank Invariant Test Procedures

20

1 reference

10.1182/BLOOD-2010-03-273243

https://api.crossref.org/works/10.1182/BLOOD-2010-03-273243

18 June 2024

A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study

22

1 reference

10.1182/BLOOD-2010-03-273243

https://api.crossref.org/works/10.1182/BLOOD-2010-03-273243

18 June 2024

A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemia. A multicentric study from the Italian Co-operative Group GIMEMA.

24

1 reference

10.1182/BLOOD-2010-03-273243

https://api.crossref.org/works/10.1182/BLOOD-2010-03-273243

18 June 2024

High-dose daunorubicin in older patients with acute myeloid leukemia

28

1 reference

10.1182/BLOOD-2010-03-273243

https://api.crossref.org/works/10.1182/BLOOD-2010-03-273243

18 June 2024

Anthracycline dose intensification in acute myeloid leukemia

29

1 reference

10.1182/BLOOD-2010-03-273243

https://api.crossref.org/works/10.1182/BLOOD-2010-03-273243

18 June 2024

Idarubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer

33

1 reference

10.1182/BLOOD-2010-03-273243

https://api.crossref.org/works/10.1182/BLOOD-2010-03-273243

18 June 2024

Idarubicin improves blast cell clearance during induction therapy in children with AML: results of study AML-BFM 93. AML-BFM Study Group

34

1 reference

10.1182/BLOOD-2010-03-273243

https://api.crossref.org/works/10.1182/BLOOD-2010-03-273243

18 June 2024

Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission

36

1 reference

10.1182/BLOOD-2010-03-273243

https://api.crossref.org/works/10.1182/BLOOD-2010-03-273243

18 June 2024

Randomized study of intensified anthracycline doses for induction and recombinant interleukin-2 for maintenance in patients with acute myeloid leukemia age 50 to 70 years: results of the ALFA-9801 study

37

1 reference

10.1182/BLOOD-2010-03-273243

https://api.crossref.org/works/10.1182/BLOOD-2010-03-273243

18 June 2024

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

38

1 reference

10.1182/BLOOD-2010-03-273243

https://api.crossref.org/works/10.1182/BLOOD-2010-03-273243

18 June 2024

Identifiers

10.1182/BLOOD-2010-03-273243

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20693429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20693429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84698071&oldid=2185042663"